Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan B

This article was originally published in The Tan Sheet

Executive Summary

Label comprehension study analysis expected by early September, after which actual use study will begin in preparation for switch NDA, Women's Capital Corp. says Aug. 1. Firm also will gather post-marketing surveillance data on nonprescription emergency contraceptive use in Europe and British Columbia along with data from U.S. pilot programs. A behavioral study on EC use underway by UC-San Francisco researchers, who began recruitment in July (1"The Tan Sheet" Jan 1, p. 12). Label comp study expected to end in late 2001, with switch application planned for early summer 2002
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS092885

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel